TapewireFind a company

person · Reporting owner

Scavilla Daniel T

Disclosed activity across 2 companies

Tapewire entity
44475
SEC CIK
0001642439

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
DENTSPLY SIRONA Inc.XRAY · Entity 4448Director · President, CEO & Member of BODMay 22, 2026May 26, 2026
GLOBUS MEDICAL INCGMED · Entity 3496Director · President, CEOJanuary 23, 2025March 28, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DENTSPLY SIRONA Inc.

Report date May 22, 2026 · Filed May 26, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect157,754 Reported balance After 2026-05-22 transaction · row 1
1 source row

Row 1 · 2026-05-22 · Tax withholding · Disposed 4,095 · Balance 157,754

F1: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.

Filing footnotes · ownership attribution and instrument terms

F1: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.

GLOBUS MEDICAL INC

Report date January 23, 2025 · Filed March 28, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $92.42 · Expires 2035-01-23Direct140,000 Reported balance After 2025-01-23 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-01-23 · Grant · Acquired 140,000 · Balance 140,000

F1: These options were granted on January 23, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Filing footnotes · ownership attribution and instrument terms

F1: These options were granted on January 23, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 22, 2026 Filed May 26, 2026 22:04 UTC DENTSPLY SIRONA Inc. XRAY · Entity 4448 Tax withholdingCommon Stock 4,095 $10.21 $41,809.95
Disclosure

SEC source: 0000818479-26-000152 · form4.xml · nonDerivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,754

F1 · shares: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:44 UTC DENTSPLY SIRONA Inc. XRAY · Entity 4448 GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative 3,554.869 $11.43 $40,632.15
Disclosure

SEC source: 0000818479-26-000114 · form4.xml · derivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,554.869

Underlying: Common Stock · 3,554.869 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.

F2 · shares: Comprised of phantom stock.

F3 · price: Supplemental Executive Retirement Plan (SERP) contribution for the year 2025 based on 12/31/25 closing price.

F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.

F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 22:25 UTC DENTSPLY SIRONA Inc. XRAY · Entity 4448 GrantStock Option (Right to Buy) · Derivative 2,066,600 $0.00 Strike: $15.46 $0.00
Disclosure

SEC source: 0000818479-26-000101 · form4.xml · derivative · entry 2

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,066,600

Underlying: Common Stock · 2,066,600 shares

Expires 2036-03-04

F2 · derivative.exercise_date: Stock options vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029, with an exercise price equal to 115% of the closing price of the Issuer's common stock as of the date of grant.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 22:25 UTC DENTSPLY SIRONA Inc. XRAY · Entity 4448 GrantCommon Stock 145,089 $0.00 $0.00
Disclosure

SEC source: 0000818479-26-000101 · form4.xml · nonDerivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,839.066

F1 · shares: Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:31 UTC DENTSPLY SIRONA Inc. XRAY · Entity 4448 Tax withholdingCommon Stock 1,194.48 $13.14 $15,695.47
Disclosure

SEC source: 0000818479-26-000074 · form4.xml · nonDerivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,750.066

F1 · shares: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:37 UTC DENTSPLY SIRONA Inc. XRAY · Entity 4448 GrantCommon Stock 245.816 $0.00 $0.00
Disclosure

SEC source: 0000818479-26-000036 · form4.xml · nonDerivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,944.546

F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

Read SEC document
October 10, 2025 Filed Oct 15, 2025 20:57 UTC DENTSPLY SIRONA Inc. XRAY · Entity 4448 GrantCommon Stock 223.681 $0.00 $0.00
Disclosure

SEC source: 0000818479-25-000217 · form4.xml · nonDerivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,698.73

F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

Read SEC document
August 08, 2025 Filed Aug 12, 2025 21:25 UTC DENTSPLY SIRONA Inc. XRAY · Entity 4448 GrantStock Option (Right to Buy) · Derivative 1,102,600 $0.00 Strike: $12.96 $0.00
Disclosure

SEC source: 0000818479-25-000162 · form4.xml · derivative · entry 2

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,102,600

Underlying: Common Stock · 1,102,600 shares

Expires 2035-08-08

F1 · derivative.exercise_date: Stock options vest in annual one-third (1/3) increments over a three (3) year period ending August 8, 2028.

Read SEC document
July 11, 2025 Filed Jul 15, 2025 22:03 UTC DENTSPLY SIRONA Inc. XRAY · Entity 4448 GrantCommon Stock 210.049 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-019224 · form4.xml · nonDerivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,475.049

Read SEC document
May 22, 2025 Filed May 27, 2025 21:24 UTC DENTSPLY SIRONA Inc. XRAY · Entity 4448 GrantCommon Stock 13,880 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-015714 · form4.xml · nonDerivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,265

F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 22:58 UTC DENTSPLY SIRONA Inc. XRAY · Entity 4448 GrantCommon Stock 3,385 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-006941 · form4.xml · nonDerivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,385

F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

Read SEC document
January 23, 2025 Filed Mar 28, 2025 22:53 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 140,000 $0.00 Strike: $92.42 $0.00
Disclosure

SEC source: 0000950170-25-047028 · ownership.xml · derivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Class A Common Stock · 140,000 shares

Expires 2035-01-23

F1 · derivative.exercise_date: These options were granted on January 23, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:29 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 80,000 $0.00 Strike: $43.58 $0.00
Disclosure

SEC source: 0000950170-24-130588 · ownership.xml · derivative · entry 5

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 80,000 shares

Expires 2029-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on January 22, 2019 and are fully vested.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:29 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 50,000 $0.00 Strike: $43.77 $0.00
Disclosure

SEC source: 0000950170-24-130588 · ownership.xml · derivative · entry 4

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 50,000 shares

Expires 2028-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on January 22, 2018 and are fully vested.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:29 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 130,000 $85.00 $11,050,000.00
Disclosure

SEC source: 0000950170-24-130588 · ownership.xml · nonDerivative · entry 3

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated June 7, 2024 executed by the reporting person.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:29 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 80,000 $43.58 $3,486,400.00
Disclosure

SEC source: 0000950170-24-130588 · ownership.xml · nonDerivative · entry 2

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:29 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 50,000 $43.77 $2,188,500.00
Disclosure

SEC source: 0000950170-24-130588 · ownership.xml · nonDerivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:23 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 30,000 $0.00 Strike: $43.77 $0.00
Disclosure

SEC source: 0000950170-24-124113 · ownership.xml · derivative · entry 5

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Class A Common Stock · 30,000 shares

Expires 2028-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on January 22, 2018 and are fully vested.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:23 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 30,000 $0.00 Strike: $26.27 $0.00
Disclosure

SEC source: 0000950170-24-124113 · ownership.xml · derivative · entry 4

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 30,000 shares

Expires 2027-01-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on January 30, 2017 and are fully vested.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:23 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 60,000 $80.02 $4,801,200.00
Disclosure

SEC source: 0000950170-24-124113 · ownership.xml · nonDerivative · entry 3

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated June 7, 2024 executed by the reporting person.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:23 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 30,000 $43.77 $1,313,100.00
Disclosure

SEC source: 0000950170-24-124113 · ownership.xml · nonDerivative · entry 2

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:23 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 30,000 $26.27 $788,100.00
Disclosure

SEC source: 0000950170-24-124113 · ownership.xml · nonDerivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 26, 2024 Filed Jan 30, 2024 21:37 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 140,000 $0.00 Strike: $53.75 $0.00
Disclosure

SEC source: 0000950170-24-008882 · ownership.xml · derivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Class A Common Stock · 140,000 shares

Expires 2034-01-26

F1 · derivative.exercise_date: These options were granted on January 26, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
October 10, 2023 Filed Oct 19, 2023 21:08 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 10,000 $0.00 Strike: $53.02 $0.00
Disclosure

SEC source: 0001209191-23-053190 · doc4.xml · derivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Class A Common Stock · 10,000 shares

Expires 2033-09-01

F1 · derivative.exercise_date: These options were granted on October 10, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on September 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
January 26, 2023 Filed Feb 27, 2023 21:49 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 100,000 $0.00 Strike: $75.18 $0.00
Disclosure

SEC source: 0001209191-23-013212 · doc4.xml · derivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2033-01-26

F1 · derivative.exercise_date: These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
April 21, 2022 Filed Apr 22, 2022 20:30 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 60,000 $0.00 Strike: $79.00 $0.00
Disclosure

SEC source: 0001209191-22-025381 · doc4.xml · derivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Class A Common Stock · 60,000 shares

Expires 2032-04-21

F1 · derivative.exercise_date: These options were granted on April 21, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on April 21, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 21:44 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 40,000 $0.00 Strike: $63.68 $0.00
Disclosure

SEC source: 0001209191-22-005581 · doc4.xml · derivative · entry 1

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Class A Common Stock · 40,000 shares

Expires 2032-01-27

F1 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
July 02, 2021 Filed Jul 7, 2021 20:46 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 50,000 $0.00 Strike: $26.27 $0.00
Disclosure

SEC source: 0001209191-21-045825 · doc4.xml · derivative · entry 6

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Class A Common Stock · 50,000 shares

Expires 2027-01-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
July 02, 2021 Filed Jul 7, 2021 20:46 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to buy Class A Common Stock) · Derivative 50,000 $0.00 Strike: $25.52 $0.00
Disclosure

SEC source: 0001209191-21-045825 · doc4.xml · derivative · entry 5

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 50,000 shares

Expires 2026-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
July 02, 2021 Filed Jul 7, 2021 20:46 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 400 $78.97 $31,588.00
Disclosure

SEC source: 0001209191-21-045825 · doc4.xml · nonDerivative · entry 4

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

Read SEC document
July 02, 2021 Filed Jul 7, 2021 20:46 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 99,600 $78.41 $7,809,636.00
Disclosure

SEC source: 0001209191-21-045825 · doc4.xml · nonDerivative · entry 3

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.83 to $78.69, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
July 02, 2021 Filed Jul 7, 2021 20:46 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 50,000 $26.27 $1,313,500.00
Disclosure

SEC source: 0001209191-21-045825 · doc4.xml · nonDerivative · entry 2

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 02, 2021 Filed Jul 7, 2021 20:46 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 50,000 $25.52 $1,276,000.00
Disclosure

SEC source: 0001209191-21-045825 · doc4.xml · nonDerivative · entry 1

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 14, 2021 Filed Jan 19, 2021 21:46 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 50,000 $0.00 Strike: $65.05 $0.00
Disclosure

SEC source: 0001209191-21-004035 · doc4.xml · derivative · entry 1

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Class A Common Stock · 50,000 shares

Expires 2031-01-14

F1 · derivative.exercise_date: These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
May 21, 2020 Filed May 26, 2020 20:30 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 68,750 $0.00 Strike: $25.52 $0.00
Disclosure

SEC source: 0001209191-20-032017 · doc4.xml · derivative · entry 5

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Class A Common Stock · 68,750 shares

Expires 2026-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
May 21, 2020 Filed May 26, 2020 20:30 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 31,250 $0.00 Strike: $25.40 $0.00
Disclosure

SEC source: 0001209191-20-032017 · doc4.xml · derivative · entry 4

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 31,250 shares

Expires 2025-04-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on April 8, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on May 4, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
May 21, 2020 Filed May 26, 2020 20:30 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 100,000 $55.09 $5,509,000.00
Disclosure

SEC source: 0001209191-20-032017 · doc4.xml · nonDerivative · entry 3

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed be the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.47, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
May 21, 2020 Filed May 26, 2020 20:30 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 68,750 $25.52 $1,754,500.00
Disclosure

SEC source: 0001209191-20-032017 · doc4.xml · nonDerivative · entry 2

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 21, 2020 Filed May 26, 2020 20:30 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 31,250 $25.40 $793,750.00
Disclosure

SEC source: 0001209191-20-032017 · doc4.xml · nonDerivative · entry 1

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 22, 2020 Filed Jan 24, 2020 21:39 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 80,000 $0.00 Strike: $53.27 $0.00
Disclosure

SEC source: 0001209191-20-004844 · doc4.xml · derivative · entry 1

Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Class A Common Stock · 80,000 shares

Expires 2030-01-22

F1 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
January 22, 2019 Filed Feb 11, 2019 21:46 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 80,000 $0.00 Strike: $43.58 $0.00
Disclosure

SEC source: 0001209191-19-008986 · doc4.xml · derivative · entry 1

Scavilla Daniel T · CIK 0001642439 · EVP, CFO, Chief Comm. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Class A Common Stock · 80,000 shares

Expires 2029-01-22

F1 · derivative.exercise_date: These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
April 10, 2018 Filed Apr 11, 2018 22:01 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 31,250 $0.00 Strike: $25.52 $0.00
Disclosure

SEC source: 0001209191-18-024686 · doc4.xml · derivative · entry 9

Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,750

Underlying: Class A Common Stock · 31,250 shares

Expires 2026-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
April 10, 2018 Filed Apr 11, 2018 22:01 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 50,540 $0.00 Strike: $25.40 $0.00
Disclosure

SEC source: 0001209191-18-024686 · doc4.xml · derivative · entry 8

Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,250

Underlying: Class A Common Stock · 50,540 shares

Expires 2025-04-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on April 8, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on May 4, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
April 10, 2018 Filed Apr 11, 2018 22:01 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 31,250 $50.00 $1,562,500.00
Disclosure

SEC source: 0001209191-18-024686 · doc4.xml · nonDerivative · entry 6

Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on March 9, 2018, which is intended to comply with Rule 10b5-1.

Read SEC document
April 10, 2018 Filed Apr 11, 2018 22:01 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 31,250 $25.52 $797,500.00
Disclosure

SEC source: 0001209191-18-024686 · doc4.xml · nonDerivative · entry 5

Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 10, 2018 Filed Apr 11, 2018 22:01 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 50,540 $50.00 $2,527,000.00
Disclosure

SEC source: 0001209191-18-024686 · doc4.xml · nonDerivative · entry 4

Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on March 9, 2018, which is intended to comply with Rule 10b5-1.

Read SEC document
April 10, 2018 Filed Apr 11, 2018 22:01 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 50,540 $25.40 $1,283,716.00
Disclosure

SEC source: 0001209191-18-024686 · doc4.xml · nonDerivative · entry 3

Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,540

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 09, 2018 Filed Apr 11, 2018 22:01 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 18,210 $0.00 Strike: $25.40 $0.00
Disclosure

SEC source: 0001209191-18-024686 · doc4.xml · derivative · entry 7

Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,790

Underlying: Class A Common Stock · 18,210 shares

Expires 2025-04-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on April 8, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on May 4, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
April 09, 2018 Filed Apr 11, 2018 22:01 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 18,210 $50.00 $910,530.96
Disclosure

SEC source: 0001209191-18-024686 · doc4.xml · nonDerivative · entry 2

Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on March 9, 2018, which is intended to comply with Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.04, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
April 09, 2018 Filed Apr 11, 2018 22:01 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 18,210 $25.40 $462,534.00
Disclosure

SEC source: 0001209191-18-024686 · doc4.xml · nonDerivative · entry 1

Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,210

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.